Merck will achieve the unique world license for Chinese language drugmaker Hansoh’s HS-10535, an experimental oral drug that targets GLP-1 receptors. Learn Extra
Merck will achieve the unique world license for Chinese language drugmaker Hansoh’s HS-10535, an experimental oral drug that targets GLP-1 receptors. Learn Extra
Sign in to your account